Dr. Chun Xia Zou holds a Master’s degree in Life Sciences and spent over a decade at the University of Alberta conducting molecular biology research, primarily within the Alberta Glycomics Centre (Dr. Cairo Lab). Her work focused on neuraminidases (NEU1, NEU3), sialic acid biology, and small-molecule inhibitor development, contributing to research in cancer biology, inflammation, and cardiovascular disease.

She has co-authored 16+ peer-reviewed publications in internationally recognized scientific journals. This academic foundation informs her evidence-informed clinical approach to acupuncture and integrative care.

• Science Advances (2018) – Immune cell modification and memory B cells
  
• Journal of the American Heart Association (2021) – Atherosclerosis and cardiovascular inflammation
  
• Journal of Neuroinflammation (2018) – Inflammatory changes in the nervous system
  
• Journal of Medicinal Chemistry (2018) – Development of selective enzyme inhibitors
  
• Communications Biology (2019) – Structural insights into human lysosomal proteins
  
• ACS Chemical Biology (2018) – Human neuraminidase isoenzyme activity
• Frontiers in Chemistry (2019) – Regulation of immune cell adhesion

 The following publications represent collaborative peer-reviewed research projects in which Dr. Chun Xia Zou served as a contributing author. 

1. A Tyrosine Sulfation–Dependent HLA-I Modification Identifies Memory B Cells and Plasma Cells.
   Science Advances. 2018; 4(11): eaar7653.
   DOI: https://doi.org/10.1126/sciadv.aar7653
2.  Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages.
   Journal of the American Heart Association. 2021; 10: e018756.
   DOI: https://doi.org/10.1161/JAHA.120.018756
3. Crystal Structures of Human Lysosomal EPDR1 Reveal Homology with the Superfamily of Bacterial Lipoprotein Transporters.
   Communications Biology. 2019; 2: 52.
   DOI: https://doi.org/10.1038/s42003-018-0262-9
4. Human Neuraminidase Isoenzymes Show Variable Activities for 9-O-Acetyl-Sialoside Substrates.
   ACS Chemical Biology. 2018; 13(4): 922–931.
   DOI: https://doi.org/10.1021/acschembio.7b00952
5. Galectin-3 Alters the Lateral Mobility and Clustering of β1-Integrin Receptors.
   PLOS ONE. 2017; 12(10): e0184378.
   DOI: https://doi.org/10.1371/journal.pone.0184378
6. Screening Glycolipids Against Proteins In Vitro Using Picodiscs and Catch-and-Release Electrospray Ionization-Mass Spectrometry.
   Analytical Chemistry. 2016; 88(9): 4742–4750.
   DOI: https://doi.org/10.1021/acs.analchem.6b00043
7. Insight into Substrate Recognition and Catalysis by the Human Neuraminidase 3 (NEU3) Through Molecular Modeling and Site-Directed Mutagenesis.
   Glycobiology. 2010; 20(9): 1127–1138.
8. Selection of Galectin-3 Ligands Derived from Genetically Encoded Glycopeptide Libraries.
   Peptide Science. 2019; e24097.
   DOI: https://doi.org/10.1002/pep2.24097

A full publication list is available upon request.